{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:15:06Z","timestamp":1788074106631,"version":"build-2784847793"},"reference-count":32,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["8020-00399B"],"award-info":[{"award-number":["8020-00399B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20OC0064048"],"award-info":[{"award-number":["NNF20OC0064048"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["20-R142-A9771-22180"],"award-info":[{"award-number":["20-R142-A9771-22180"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Hypokalaemia and low-normal plasma potassium levels are associated with increased risk of atrial fibrillation. This study examined if potassium-increasing treatment reduces the risk of atrial fibrillation-related clinical events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prespecified analysis of the POTCAST trial. Adults with an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D) and plasma potassium \u22644.3\u2005mmol\/L were randomized to potassium-increasing treatment and standard care (high-normal potassium group) or standard care alone (control group). The endpoint was a composite of acute hospitalizations due to atrial fibrillation leading to a change in pharmacological treatment or due to inappropriate shock therapy, hospitalization for electrical cardioversion or ablation of atrial fibrillation, and loading with amiodarone for atrial fibrillation. The endpoint was evaluated in time-to-first-event analyses with death as competing risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1200 participants [600 in each group, median age 64 years (interquartile range, 56\u201372), 80.3% male], 390 (32.5%) had a history of atrial fibrillation. Plasma potassium increased by .3\u2005mmol\/L after uptitration in the high-normal potassium group compared with the controls. After a median follow-up of 3.3 person-years, the endpoint had occurred in 48 participants in the high-normal potassium group (8.0%, 2.80 events per 100 person-years), when compared with 73 participants in the control group (12.2%, 4.30 events per 100 person-years) (subdistribution hazard ratio, .65; 95% confidence interval, .45\u2013.93, P = .02). The treatment effect appeared similar across subgroups, including those with vs without a history of atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In adults with any cardiac disease, treated with an ICD or CRT-D, uptitration of plasma potassium levels within the normal range reduced the risk of atrial fibrillation-related clinical events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag436","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:47:46Z","timestamp":1778845666000},"source":"Crossref","is-referenced-by-count":0,"title":["Increasing plasma potassium and risk of atrial fibrillation: the POTCAST trial"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-8560","authenticated-orcid":false,"given":"Chaoqun","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2165-9555","authenticated-orcid":false,"given":"Ulrik Christian Gudbrand","family":"Winsl\u00f8w","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6967-4577","authenticated-orcid":false,"given":"Elisabeth Margrethe","family":"Danielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-7311","authenticated-orcid":false,"given":"Tharsika","family":"Sakthivel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0504-8487","authenticated-orcid":false,"given":"Kasper Karmark","family":"Iversen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Herlev and Gentofte , Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5910-0354","authenticated-orcid":false,"given":"Helle Skovmand","family":"Bosselmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zealand University Hospital\u2014Roskilde , Roskilde ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-9164","authenticated-orcid":false,"given":"Niels","family":"Risum","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-2623","authenticated-orcid":false,"given":"Christian","family":"J\u00f8ns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-7049","authenticated-orcid":false,"given":"Henning","family":"Bundgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2026083002521818400_ehag436-B1","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1016\/j.ijcard.2013.08.048","article-title":"Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study","volume":"168","author":"Krijthe","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026083002521818400_ehag436-B2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/00015385.2020.1799573","article-title":"Low serum potassium levels are associated with the risk of atrial fibrillation","volume":"76","author":"Farah","year":"2021","journal-title":"Acta Cardiol"},{"key":"2026083002521818400_ehag436-B3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12864-024-10197-2","article-title":"Serum electrolyte concentrations and risk of atrial fibrillation: an observational and Mendelian randomization study","volume":"25","author":"Wu","year":"2024","journal-title":"BMC Genomics"},{"key":"2026083002521818400_ehag436-B4","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1093\/eurheartj\/ehaf623","article-title":"Hypokalaemia and atrial fibrillation detected by implanted loop recorders","volume":"46","author":"Hessellund","year":"2025","journal-title":"Eur Heart J"},{"key":"2026083002521818400_ehag436-B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/CIRCRESAHA.119.315641","article-title":"Hypokalemia promotes arrhythmia by distinct mechanisms in atrial and ventricular myocytes","volume":"126","author":"Tazmini","year":"2020","journal-title":"Circ Res"},{"key":"2026083002521818400_ehag436-B6","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026083002521818400_ehag436-B7","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (eplerenone in mild patients hospitalization and SurvIval study in heart failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026083002521818400_ehag436-B8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/eurheartj\/ehad811","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials","volume":"45","author":"Oraii","year":"2024","journal-title":"Eur Heart J"},{"key":"2026083002521818400_ehag436-B9","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jacc.2025.03.429","article-title":"Finerenone reduces new-onset atrial fibrillation across the Spectrum of cardio-kidney-metabolic syndrome: the FINE-HEART pooled analysis","volume":"85","author":"Pabon","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026083002521818400_ehag436-B10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"2026083002521818400_ehag436-B11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026083002521818400_ehag436-B12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026083002521818400_ehag436-B13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa2509542","article-title":"Increasing the potassium level in patients at high risk for ventricular arrhythmias","volume":"393","author":"J\u00f8ns","year":"2025","journal-title":"N Engl J Med"},{"key":"2026083002521818400_ehag436-B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ahj.2022.07.003","article-title":"Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): study protocol for a randomized controlled trial","volume":"253","author":"Winsl\u00f8w","year":"2022","journal-title":"Am Heart J"},{"key":"2026083002521818400_ehag436-B15","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.amjcard.2016.08.078","article-title":"Serum potassium levels and outcome in patients with chronic heart failure","volume":"118","author":"Hoss","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026083002521818400_ehag436-B16","unstructured":"R Core Team\n          . R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/"},{"key":"2026083002521818400_ehag436-B17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004667","article-title":"Electrophysiology of hypokalemia and hyperkalemia","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026083002521818400_ehag436-B18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.hrthm.2015.12.005","article-title":"Electrolyte disturbances differentially regulate sinoatrial node and pulmonary vein electrical activity: a contribution to hypokalemia- or hyponatremia-induced atrial fibrillation","volume":"13","author":"Lu","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026083002521818400_ehag436-B19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/j.hrthm.2024.06.020","article-title":"Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation","volume":"21","author":"Yang","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026083002521818400_ehag436-B20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ahj.2019.12.014","article-title":"Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial","volume":"221","author":"Tazmini","year":"2020","journal-title":"Am Heart J"},{"key":"2026083002521818400_ehag436-B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.37234","article-title":"Association of intravenous potassium and magnesium administration with spontaneous conversion of atrial fibrillation and atrial flutter in the emergency department","volume":"5","author":"Cacioppo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026083002521818400_ehag436-B22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jama.2024.17888","article-title":"Potassium supplementation and prevention of atrial fibrillation after cardiac surgery: the TIGHT K randomized clinical trial","volume":"332","author":"O\u2019Brien","year":"2024","journal-title":"JAMA"},{"key":"2026083002521818400_ehag436-B23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.athoracsur.2016.06.066","article-title":"Potassium and magnesium supplementation do not protect against atrial fibrillation after cardiac operation: a time-matched analysis","volume":"102","author":"Lancaster","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2026083002521818400_ehag436-B24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2026083002521818400_ehag436-B25","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026083002521818400_ehag436-B26","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"2026083002521818400_ehag436-B27","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur Heart J"},{"key":"2026083002521818400_ehag436-B28","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur Heart J"},{"key":"2026083002521818400_ehag436-B29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.26187","article-title":"Aldosterone and the mineralocorticoid receptor in atrial fibrillation","volume":"83","author":"Mamazhakypov","year":"2026","journal-title":"Hypertension"},{"key":"2026083002521818400_ehag436-B30","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"2026083002521818400_ehag436-B31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2021.04.079","article-title":"Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes","volume":"78","author":"Filippatos","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026083002521818400_ehag436-B32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag436\/70828176\/ehag436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag436\/70828176\/ehag436.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:52:24Z","timestamp":1788072744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag436\/8772347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag436","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"article-number":"ehag436"}}